Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 20854235)

1.

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.

Glasziou PP, Clarke P, Alexander J, Rajmokan M, Beller E, Woodward M, Chalmers J, Poulter N, Patel A.

Med J Aust. 2010 Sep 20;193(6):320-4.

PMID:
20854235
2.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.

PMID:
17765963
3.
4.

The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.

Waeber B, de la Sierra A, Ruilope LM.

Am J Cardiovasc Drugs. 2009;9(5):283-91. doi: 10.2165/10061600-000000000-00000. Review.

PMID:
19791837
6.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial.

Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group.

J Hypertens. 2010 Jun;28(6):1141-9.

PMID:
20486273
7.
8.

Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.

Chalmers J, Joshi R, Kengne AP, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A; ADVANCE Collaborative Group.

J Hypertens Suppl. 2008 Sep;26(3):S21-7. Review.

PMID:
19363849
9.
10.

Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.

Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y, Zoungas S, Patel A, Williams B, Harrap S.

Hypertension. 2014 Feb;63(2):259-64. doi: 10.1161/HYPERTENSIONAHA.113.02252. Epub 2013 Dec 9.

11.

An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.

Tavakoli M, Pumford N, Woodward M, Doney A, Chalmers J, MacMahon S, Macwalter R.

Eur J Health Econ. 2009 Feb;10(1):111-9. doi: 10.1007/s10198-008-0108-3. Epub 2008 Apr 30.

PMID:
18446392
12.

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

Glasziou PP, Eckermann SD, Mulray SE, Simes RJ, Martin AJ, Kirby AC, Hall JP, Caleo S, White HD, Tonkin AM.

Med J Aust. 2002 Oct 21;177(8):428-34.

PMID:
12381252
13.

ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.

Perkovic V, Joshi R, Patel A, Bompoint S, Chalmers J; ADVANCE Collaborative Group.

Blood Press. 2006;15(6):340-6.

PMID:
17472024
14.
15.

Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.

Chalmers J, Joshi R, Kengne AP, MacMahon S.

J Hypertens Suppl. 2008 Jun;26(2):S11-5.

PMID:
18979718
16.

Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].

Ghiadoni L.

Expert Opin Pharmacother. 2010 Jul;11(10):1647-57. doi: 10.1517/14656566.2010.491511. Erratum in: Expert Opin Pharmacother. 2010 Aug;11(11);1963.

PMID:
20518617
17.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
18.

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee.

Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25.

PMID:
19633827
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk